Approval · Notice of Compliance 24845 · 2020
RYTHMODAN: Notice of Compliance 24845
Issued December 18, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24845
- Date
- December 18, 2020
- Company
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RYTHMODAN | 02224801 | Dormant |
Medicinal ingredients
- DISOPYRAMIDE 100 MG per CAP